APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic TumorsNitin Roper, Udayan Guha, Constance M. Cultraro et al.|Cell Reports|2019Cited by 108
Temporarily Deferred Therapy (watchful waiting) for Men Younger Than 70 Years and With Low-Risk Localized Prostate Cancer in the Prostate-Specific Antigen EraCorey A. Carter, Judd W. Moul, Timothy F. Donahue et al.|Journal of Clinical Oncology|2003Cited by 81
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an “exceptional responder” lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment responseRomi Biswas, Udayan Guha, Shaojian Gao et al.|Molecular Case Studies|2016Cited by 24